Airmed

Airmed Pathology Labs operates in the diagnostics and pathology sector, providing home-based and lab-based medical testing services. The company serves both direct consumers and patients referred by doctors and hospitals, with a growing presence in Ahmedabad and plans for pan-India expansion.Offers a comprehensive suite of diagnostic tests, wellness packages, and technology-driven pathology solutions. Airmed integrates unutilized capacity in the diagnostics industry, leveraging back-end technology to build a scalable, asset-light network of labs and collection centers.

 Core Products and Services

• Home-Based Diagnostic Testing: Comprehensive menu of blood tests, wellness panels, and preventive health packages, all available for home sample collection with 24/7 service and emergency support.

• Lab-Based Testing & Network Integration: Asset-light model that outsources demand to local pathology labs, improving their capacity utilization and operational efficiency through technology.

• Digital Platform & App: Enables patients to book tests, schedule sample collection, and access digital reports via web, app, or phone, streamlining the entire diagnostic journey.

• SafePrick Technology: Proprietary, nearly painless blood collection method, enhancing patient comfort and compliance.

• Doctor & Hospital Support: Provides best-in-class diagnostic support to referring doctors and hospitals, including analytics-driven consultation and follow-up services for critical cases.

• Wellness Packages: Custom health packages addressing specific needs (e.g., diabetes, obesity, hair loss), designed by in-house experts

 Business Model & Revenue Streams

• Revenue Generation: Core revenue from diagnostic test fees paid by individual patients, doctors, and hospitals.B2B revenue from partnerships with local labs, leveraging Airmed’s technology to drive higher throughput and efficiency.

• Asset-Light, Scalable Model: By integrating with existing labs and focusing on technology, Airmed minimizes capital expenditure and scales rapidly across geographies.

• Digital & Subscription Revenue: The app and digital platform enable recurring revenue through health subscriptions and value-added services.

Customer Segmentation

• B2C: Direct-to-consumer home testing and wellness packages form the majority of revenue.

• B2B: Partnerships with local labs and hospitals, as well as doctor referrals, contribute a significant share.

Top Clients & Partnerships

• Local Pathology Labs: Airmed’s core B2B partners, benefiting from increased demand and improved operational efficiency through Airmed’s tech platform.

• Hospitals & Doctors: Key referral partners, leveraging Airmed’s diagnostic support and analytics for patient care.

• Brand Capital (BCCL): Strategic investor, providing both capital and media support to drive brand awareness and market expansion.

• Technology & Logistics Partners: Collaborations for IoT, barcoding, and logistics to ensure sample integrity and rapid turnaround.

• Client Concentration & Diversification: No single client or partner dominates revenue; the business is diversified across B2C and B2B channels, with a growing network of labs and collection centers reducing concentration risk.

 Future Outlook & Strategic Priorities

• Geographic Expansion: Aggressive rollout into Delhi, Gurugram, and the rest of Gujarat, with a target of 100+ labs and 10,000 annual samples processed (reflecting recent market trends).

• Technology & Digital Innovation: Continued investment in the app, analytics, and IoT/barcoding to enhance patient experience, operational efficiency, and sample integrity.

• Brand Building: Leveraging recent funding to increase brand salience, customer acquisition, and market penetration, especially in Tier 2/3 cities.

• Service Diversification: Expansion of wellness packages, preventive health offerings, and subscription-based models to drive recurring revenue.